Muscleblind-like 1 is required for normal heart valve development in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Muscleblind-like 1 is required for normal heart valve development in vivo
Authors
Keywords
Muscleblind-like 1, Transforming growth factor β, Epithelial-mesenchymal transition, Endocardial cushions, Heart valves, Mouse
Journal
BMC DEVELOPMENTAL BIOLOGY
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-15
DOI
10.1186/s12861-015-0087-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using optical coherence tomography to rapidly phenotype and quantify congenital heart defects associated with prenatal alcohol exposure
- (2015) Ganga Karunamuni et al. DEVELOPMENTAL DYNAMICS
- Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
- (2015) Donald M. Dixon et al. Scientific Reports
- Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1
- (2014) Stewart M. Coleman et al. BIOCHEMICAL JOURNAL
- Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis
- (2014) A. W. Cheng et al. BLOOD
- Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins
- (2014) Yoshihiro Kino et al. HUMAN MOLECULAR GENETICS
- Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease
- (2014) Ranjan Batra et al. MOLECULAR CELL
- Genetics of Valvular Heart Disease
- (2014) Stephanie LaHaye et al. Current Cardiology Reports
- Ethanol exposure alters early cardiac function in the looping heart: a mechanism for congenital heart defects?
- (2013) Ganga Karunamuni et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- ClearT: a detergent- and solvent-free clearing method for neuronal and non-neuronal tissue
- (2013) T. Kuwajima et al. DEVELOPMENT
- Compound loss of muscleblind-like function in myotonic dystrophy
- (2013) Kuang-Yung Lee et al. EMBO Molecular Medicine
- Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves
- (2013) Damien N. Barnette et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MBNL proteins repress ES-cell-specific alternative splicing and reprogramming
- (2013) Hong Han et al. NATURE
- Gene Expression Analyses Implicate an Alternative Splicing Program in Regulating Contractile Gene Expression and Serum Response Factor Activity in Mice
- (2013) Twishasri Dasgupta et al. PLoS One
- MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation
- (2013) Julian P. Venables et al. Nature Communications
- Progressive Anatomical Closure of Foramen Ovale in Normal Neonatal Mouse Hearts
- (2012) Colleen T. Cole-Jeffrey et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Loss of muscleblind-like 1 promotes invasive mesenchyme formation in endocardial cushions by stimulating autocrine TGFβ3
- (2012) Kathryn E LeMasters et al. BMC DEVELOPMENTAL BIOLOGY
- Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins
- (2012) Eric T. Wang et al. CELL
- Evolutionary functional analysis and molecular regulation of the ZEB transcription factors
- (2012) Alexander Gheldof et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion
- (2012) Laura E. Briggs et al. DIFFERENTIATION
- Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease
- (2012) Jonathan D. Cheek et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy
- (2012) Konstantinos Charizanis et al. NEURON
- Analysis of Osteopontin Levels for the Identification of Asymptomatic Patients With Calcific Aortic Valve Disease
- (2011) Juan B. Grau et al. ANNALS OF THORACIC SURGERY
- Heart Valve Structure and Function in Development and Disease
- (2011) Robert B. Hinton et al. Annual Review of Physiology
- Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease
- (2011) Rachana Sainger et al. BIOMARKERS
- Molecular and developmental mechanisms of congenital heart valve disease
- (2011) Joy Lincoln et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- What chick and mouse models have taught us about the role of the endocardium in congenital heart disease
- (2011) Daniel M. DeLaughter et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Myotonic Dystrophies and the Heart
- (2011) Sunit-Preet Chaudhry et al. Cardiology in Review
- Transforming growth factor Beta2 is required for valve remodeling during heart development
- (2011) Mohamad Azhar et al. DEVELOPMENTAL DYNAMICS
- Longitudinal Imaging of Heart Development With Optical Coherence Tomography
- (2011) Michael W. Jenkins et al. IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
- Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy
- (2011) Frédérique Rau et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Sox9 Transcriptionally Represses Spp1 to Prevent Matrix Mineralization in Maturing Heart Valves and Chondrocytes
- (2011) Jacqueline D. Peacock et al. PLoS One
- Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
- (2010) Benedikt Schoser et al. CURRENT GENOMICS
- Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity
- (2010) Fulvia Terenzi et al. RNA Biology
- Opposite Effects of Transforming Growth Factor-β1 and Vascular Endothelial Growth Factor on the Degeneration of Aortic Valvular Interstitial Cell Are Modified by the Extracellular Matrix Protein Fibronectin: Implications for Heart Valve Engineering
- (2010) Patricia Gwanmesia et al. TISSUE ENGINEERING PART A
- Muscleblind-like 1 is a negative regulator of TGF-β-dependent epithelialâmesenchymal transition of atrioventricular canal endocardial cells
- (2009) Natalie A. Vajda et al. DEVELOPMENTAL DYNAMICS
- Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development
- (2009) Mohamad Azhar et al. DEVELOPMENTAL DYNAMICS
- Melanocyte pigmentation stiffens murine cardiac tricuspid valve leaflet
- (2009) K. Balani et al. Journal of the Royal Society Interface
- Periostin regulates atrioventricular valve maturation
- (2008) Russell A. Norris et al. DEVELOPMENTAL BIOLOGY
- Identification of erythroid-enriched gene expression in the mouse embryonic yolk sac using microdissected cells
- (2008) Latasha C. Redmond et al. DEVELOPMENTAL DYNAMICS
- The location of heart melanocytes is specified and the level of pigmentation in the heart may correlate with coat color
- (2008) Ichiro Yajima et al. Pigment Cell & Melanoma Research
- Timeline and distribution of melanocyte precursors in the mouse heart
- (2008) Flavia Carneiro Brito et al. Pigment Cell & Melanoma Research
- A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
- (2008) A. Kalsotra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started